Home/Filings/4/A/0001493152-19-003370
4/A//SEC Filing

HEAD JONATHAN FREDERICK 4/A

Accession 0001493152-19-003370

CIK 0001362703other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:47 PM ET

Size

5.4 KB

Accession

0001493152-19-003370

Insider Transaction Report

Form 4/AAmended
Period: 2015-09-02
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
  • Award

    Series A Preferred Stock

    2015-09-02+500,000500,000 total
Footnotes (2)
  • [F1]These shares of Series A Preferred were omitted from the reporting person's original Form 4.
  • [F2]Received, in addition to shares of common stock of the registrant, in exchange for all of the reporting person's shares of OncBioMune, Inc. ("ONC") common stock in connection with the exchange pursuant to that certain exchange agreement dated as of June 22, 2015, as amended, among the registrant, ONC and the ONC shareholders.

Documents

1 file

Issuer

OncBioMune Pharmaceuticals, Inc

CIK 0001362703

Entity typeother

Related Parties

1
  • filerCIK 0001653951

Filing Metadata

Form type
4/A
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:47 PM ET
Size
5.4 KB